img

Global Oral Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
Oral Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Vaccines market is projected to reach US$ 3333.6 million in 2034, increasing from US$ 2474 million in 2022, with the CAGR of 4.3% during the period of 2024 to 2034. Demand from Public and Private are the major drivers for the industry.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine

Segment by Application


Public
Private

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Oral Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oral Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Vaccines introduction, etc. Oral Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Oral Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Oral Vaccines Market Overview
1.1 Oral Vaccines Product Overview
1.2 Oral Vaccines Market Segment by Type
1.2.1 Rotavirus Vaccine
1.2.2 Cholera Vaccine
1.2.3 Oral Polio Vaccine
1.3 Global Oral Vaccines Market Size by Type
1.3.1 Global Oral Vaccines Market Size Overview by Type (2018-2034)
1.3.2 Global Oral Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Oral Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oral Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Oral Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Oral Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Oral Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Oral Vaccines Sales Breakdown by Type (2018-2024)
2 Global Oral Vaccines Market Competition by Company
2.1 Global Top Players by Oral Vaccines Sales (2018-2024)
2.2 Global Top Players by Oral Vaccines Revenue (2018-2024)
2.3 Global Top Players by Oral Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Oral Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oral Vaccines Market Competitive Situation and Trends
2.5.1 Oral Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Oral Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Oral Vaccines Market
2.8 Key Manufacturers Oral Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oral Vaccines Status and Outlook by Region
3.1 Global Oral Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Oral Vaccines Historic Market Size by Region
3.2.1 Global Oral Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Oral Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Oral Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Oral Vaccines Forecasted Market Size by Region
3.3.1 Global Oral Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Oral Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Oral Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Oral Vaccines by Application
4.1 Oral Vaccines Market Segment by Application
4.1.1 Public
4.1.2 Private
4.2 Global Oral Vaccines Market Size by Application
4.2.1 Global Oral Vaccines Market Size Overview by Application (2018-2034)
4.2.2 Global Oral Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Oral Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oral Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Oral Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Oral Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Oral Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Oral Vaccines Sales Breakdown by Application (2018-2024)
5 North America Oral Vaccines by Country
5.1 North America Oral Vaccines Historic Market Size by Country
5.1.1 North America Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Oral Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Oral Vaccines Sales in Value by Country (2018-2024)
5.2 North America Oral Vaccines Forecasted Market Size by Country
5.2.1 North America Oral Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Oral Vaccines Sales in Value by Country (2024-2034)
6 Europe Oral Vaccines by Country
6.1 Europe Oral Vaccines Historic Market Size by Country
6.1.1 Europe Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Oral Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Oral Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Oral Vaccines Forecasted Market Size by Country
6.2.1 Europe Oral Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Oral Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Oral Vaccines by Region
7.1 Asia-Pacific Oral Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Oral Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Oral Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Oral Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Oral Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Oral Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Oral Vaccines Sales in Value by Region (2024-2034)
8 Latin America Oral Vaccines by Country
8.1 Latin America Oral Vaccines Historic Market Size by Country
8.1.1 Latin America Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Oral Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Oral Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Oral Vaccines Forecasted Market Size by Country
8.2.1 Latin America Oral Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Oral Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Oral Vaccines by Country
9.1 Middle East and Africa Oral Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Oral Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Oral Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Oral Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Oral Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Oral Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck Oral Vaccines Products Offered
10.1.5 Merck Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GSK Oral Vaccines Products Offered
10.2.5 GSK Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi Oral Vaccines Products Offered
10.3.5 Sanofi Recent Development
10.4 Lanzhou Institute
10.4.1 Lanzhou Institute Company Information
10.4.2 Lanzhou Institute Introduction and Business Overview
10.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Lanzhou Institute Oral Vaccines Products Offered
10.4.5 Lanzhou Institute Recent Development
10.5 Serum Institute
10.5.1 Serum Institute Company Information
10.5.2 Serum Institute Introduction and Business Overview
10.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Serum Institute Oral Vaccines Products Offered
10.5.5 Serum Institute Recent Development
10.6 Valneva
10.6.1 Valneva Company Information
10.6.2 Valneva Introduction and Business Overview
10.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Valneva Oral Vaccines Products Offered
10.6.5 Valneva Recent Development
10.7 Shanghai United Cell
10.7.1 Shanghai United Cell Company Information
10.7.2 Shanghai United Cell Introduction and Business Overview
10.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Shanghai United Cell Oral Vaccines Products Offered
10.7.5 Shanghai United Cell Recent Development
10.8 Bibcol
10.8.1 Bibcol Company Information
10.8.2 Bibcol Introduction and Business Overview
10.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bibcol Oral Vaccines Products Offered
10.8.5 Bibcol Recent Development
10.9 PaxVax
10.9.1 PaxVax Company Information
10.9.2 PaxVax Introduction and Business Overview
10.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.9.4 PaxVax Oral Vaccines Products Offered
10.9.5 PaxVax Recent Development
10.10 Vabiotech
10.10.1 Vabiotech Company Information
10.10.2 Vabiotech Introduction and Business Overview
10.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Vabiotech Oral Vaccines Products Offered
10.10.5 Vabiotech Recent Development
10.11 Tiantan Biological
10.11.1 Tiantan Biological Company Information
10.11.2 Tiantan Biological Introduction and Business Overview
10.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Tiantan Biological Oral Vaccines Products Offered
10.11.5 Tiantan Biological Recent Development
10.12 EuBiologics
10.12.1 EuBiologics Company Information
10.12.2 EuBiologics Introduction and Business Overview
10.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.12.4 EuBiologics Oral Vaccines Products Offered
10.12.5 EuBiologics Recent Development
10.13 Panacea Biotec Ltd
10.13.1 Panacea Biotec Ltd Company Information
10.13.2 Panacea Biotec Ltd Introduction and Business Overview
10.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Panacea Biotec Ltd Oral Vaccines Products Offered
10.13.5 Panacea Biotec Ltd Recent Development
10.14 Bio-Med
10.14.1 Bio-Med Company Information
10.14.2 Bio-Med Introduction and Business Overview
10.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Bio-Med Oral Vaccines Products Offered
10.14.5 Bio-Med Recent Development
10.15 Halfkin Bio-Pharmaceuticals
10.15.1 Halfkin Bio-Pharmaceuticals Company Information
10.15.2 Halfkin Bio-Pharmaceuticals Introduction and Business Overview
10.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Products Offered
10.15.5 Halfkin Bio-Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oral Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oral Vaccines Industrial Chain Analysis
11.4 Oral Vaccines Market Dynamics
11.4.1 Oral Vaccines Industry Trends
11.4.2 Oral Vaccines Market Drivers
11.4.3 Oral Vaccines Market Challenges
11.4.4 Oral Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oral Vaccines Distributors
12.3 Oral Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Rotavirus Vaccine
Table 2. Major Company of Cholera Vaccine
Table 3. Major Company of Oral Polio Vaccine
Table 4. Global Oral Vaccines Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Oral Vaccines Sales by Type (2018-2024) & (K Units)
Table 6. Global Oral Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Oral Vaccines Sales by Type (2018-2024) & (US& Million)
Table 8. Global Oral Vaccines Market Share in Value by Type (2018-2024)
Table 9. Global Oral Vaccines Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Oral Vaccines Sales by Type (2024-2034) & (K Units)
Table 11. Global Oral Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Oral Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Oral Vaccines Sales Market Share in Value by Type (2024-2034)
Table 14. Global Oral Vaccines Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Oral Vaccines Sales by Type (2018-2024) & (K Units)
Table 16. North America Oral Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Oral Vaccines Sales (K Units) by Type (2018-2024)
Table 18. Europe Oral Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Oral Vaccines Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Oral Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Oral Vaccines Sales (K Units) by Type (2018-2024)
Table 22. Latin America Oral Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Oral Vaccines Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Oral Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Oral Vaccines Sales by Company (2018-2024) & (K Units)
Table 26. Global Oral Vaccines Sales Share by Company (2018-2024)
Table 27. Global Oral Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Oral Vaccines Revenue Share by Company (2018-2024)
Table 29. Global Market Oral Vaccines Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Oral Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Oral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Vaccines as of 2022)
Table 33. Date of Key Manufacturers Enter into Oral Vaccines Market
Table 34. Key Manufacturers Oral Vaccines Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Oral Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Oral Vaccines Sales by Region (2018-2024) & (K Units)
Table 38. Global Oral Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Oral Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Oral Vaccines Sales Market Share in Value by Region (2018-2024)
Table 41. Global Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Oral Vaccines Sales by Region (2024-2034) & (K Units)
Table 43. Global Oral Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Oral Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Oral Vaccines Sales Market Share in Value by Region (2024-2034)
Table 46. Global Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Oral Vaccines Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Oral Vaccines Sales by Application (2018-2024) & (K Units)
Table 49. Global Oral Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Oral Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Oral Vaccines Sales Market Share in Value by Application (2018-2024)
Table 52. Global Oral Vaccines Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Oral Vaccines Sales by Application (2024-2034) & (K Units)
Table 54. Global Oral Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Oral Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Oral Vaccines Sales Market Share in Value by Application (2024-2034)
Table 57. Global Oral Vaccines Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Oral Vaccines Sales by Application (2018-2024) (K Units)
Table 59. North America Oral Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Oral Vaccines Sales by Application (2018-2024) (K Units)
Table 61. Europe Oral Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Oral Vaccines Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Oral Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Oral Vaccines Sales by Application (2018-2024) (K Units)
Table 65. Latin America Oral Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Oral Vaccines Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Oral Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Oral Vaccines Sales by Country (2018-2024) & (K Units)
Table 69. North America Oral Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Oral Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Oral Vaccines Sales Market Share in Value by Country (2018-2024)
Table 72. North America Oral Vaccines Sales by Country (2024-2034) & (K Units)
Table 73. North America Oral Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Oral Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Oral Vaccines Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Oral Vaccines Sales by Country (2018-2024) & (K Units)
Table 77. Europe Oral Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Oral Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Oral Vaccines Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Oral Vaccines Sales by Country (2024-2034) & (K Units)
Table 81. Europe Oral Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Oral Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Oral Vaccines Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Oral Vaccines Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Oral Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Oral Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Oral Vaccines Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Oral Vaccines Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Oral Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Oral Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Oral Vaccines Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Oral Vaccines Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Oral Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Oral Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Oral Vaccines Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Oral Vaccines Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Oral Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Oral Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Oral Vaccines Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Oral Vaccines Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Oral Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Oral Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Oral Vaccines Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Oral Vaccines Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Oral Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Oral Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Oral Vaccines Sales Market Share in Value by Country (2024-2034)
Table 108. Merck Company Information
Table 109. Merck Introduction and Business Overview
Table 110. Merck Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Merck Oral Vaccines Product
Table 112. Merck Recent Development
Table 113. GSK Company Information
Table 114. GSK Introduction and Business Overview
Table 115. GSK Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. GSK Oral Vaccines Product
Table 117. GSK Recent Development
Table 118. Sanofi Company Information
Table 119. Sanofi Introduction and Business Overview
Table 120. Sanofi Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Sanofi Oral Vaccines Product
Table 122. Sanofi Recent Development
Table 123. Lanzhou Institute Company Information
Table 124. Lanzhou Institute Introduction and Business Overview
Table 125. Lanzhou Institute Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Lanzhou Institute Oral Vaccines Product
Table 127. Lanzhou Institute Recent Development
Table 128. Serum Institute Company Information
Table 129. Serum Institute Introduction and Business Overview
Table 130. Serum Institute Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Serum Institute Oral Vaccines Product
Table 132. Serum Institute Recent Development
Table 133. Valneva Company Information
Table 134. Valneva Introduction and Business Overview
Table 135. Valneva Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Valneva Oral Vaccines Product
Table 137. Valneva Recent Development
Table 138. Shanghai United Cell Company Information
Table 139. Shanghai United Cell Introduction and Business Overview
Table 140. Shanghai United Cell Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Shanghai United Cell Oral Vaccines Product
Table 142. Shanghai United Cell Recent Development
Table 143. Bibcol Company Information
Table 144. Bibcol Introduction and Business Overview
Table 145. Bibcol Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Bibcol Oral Vaccines Product
Table 147. Bibcol Recent Development
Table 148. PaxVax Company Information
Table 149. PaxVax Introduction and Business Overview
Table 150. PaxVax Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. PaxVax Oral Vaccines Product
Table 152. PaxVax Recent Development
Table 153. Vabiotech Company Information
Table 154. Vabiotech Introduction and Business Overview
Table 155. Vabiotech Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Vabiotech Oral Vaccines Product
Table 157. Vabiotech Recent Development
Table 158. Tiantan Biological Company Information
Table 159. Tiantan Biological Introduction and Business Overview
Table 160. Tiantan Biological Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Tiantan Biological Oral Vaccines Product
Table 162. Tiantan Biological Recent Development
Table 163. EuBiologics Company Information
Table 164. EuBiologics Introduction and Business Overview
Table 165. EuBiologics Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. EuBiologics Oral Vaccines Product
Table 167. EuBiologics Recent Development
Table 168. Panacea Biotec Ltd Company Information
Table 169. Panacea Biotec Ltd Introduction and Business Overview
Table 170. Panacea Biotec Ltd Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Panacea Biotec Ltd Oral Vaccines Product
Table 172. Panacea Biotec Ltd Recent Development
Table 173. Bio-Med Company Information
Table 174. Bio-Med Introduction and Business Overview
Table 175. Bio-Med Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Bio-Med Oral Vaccines Product
Table 177. Bio-Med Recent Development
Table 178. Halfkin Bio-Pharmaceuticals Company Information
Table 179. Halfkin Bio-Pharmaceuticals Introduction and Business Overview
Table 180. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 181. Halfkin Bio-Pharmaceuticals Oral Vaccines Product
Table 182. Halfkin Bio-Pharmaceuticals Recent Development
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Oral Vaccines Market Trends
Table 186. Oral Vaccines Market Drivers
Table 187. Oral Vaccines Market Challenges
Table 188. Oral Vaccines Market Restraints
Table 189. Oral Vaccines Distributors List
Table 190. Oral Vaccines Downstream Customers
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Vaccines Product Picture
Figure 2. Global Oral Vaccines Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Oral Vaccines Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Oral Vaccines Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Rotavirus Vaccine
Figure 6. Global Rotavirus Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Cholera Vaccine
Figure 8. Global Cholera Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Oral Polio Vaccine
Figure 10. Global Oral Polio Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Oral Vaccines Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Oral Vaccines Sales Market Share by Type in 2022 & 2034
Figure 13. North America Oral Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. North America Oral Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Europe Oral Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Europe Oral Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Oral Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Oral Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Latin America Oral Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Oral Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Oral Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Oral Vaccines Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Vaccines Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Vaccines Revenue in 2022
Figure 25. Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Public
Figure 27. Global Public Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Private
Figure 29. Global Private Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Global Oral Vaccines Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Oral Vaccines Sales Market Share by Application in 2022 & 2034
Figure 32. North America Oral Vaccines Sales Market Share in Volume by Application in 2022
Figure 33. North America Oral Vaccines Sales Market Share in Value by Application in 2022
Figure 34. Europe Oral Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. Europe Oral Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Oral Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Oral Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Latin America Oral Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Oral Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Oral Vaccines Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Oral Vaccines Manufacturing Cost Structure
Figure 43. Oral Vaccines Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries